{"id":625115,"title":"Overview: Annex 2 to the Good manufacturing practices guide - Manufacture of biologics (GUI-0027) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T08:38:08.443000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-2-current-edition-guidelines-schedule-drugs-biological-drugs-0027.html","snippet":"Annex 2 to the Good manufacturing practices guide - Manufacture of biologics (GUI-0027): Overview Overview Quality risk management principles General guidance Guidance on product types Glossary and definitions References Date issued: 04-07-2024 Date implemented: 04-07-2024…","rawSnapshotUrl":"/api/snapshots/raw/625115","browseUrl":"https://replay.healtharchive.ca/job-6/20260227083808/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-2-current-edition-guidelines-schedule-drugs-biological-drugs-0027.html#ha_snapshot=625115","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}